InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Peter Evan Harwin, Director, is a corporate insider tracked by InsiderTape across 4 companies. The public record shows 5 open-market SEC Form 4 transactions: 4 purchases worth $29.7M and 1 sale worth $133.5M, reported from Sep 29, 23 to Jan 22, 26. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 22, 26 | APGEApogee Therapeutics, Inc. | SELL | 1.75M | $76.30 | $133.5M |
| Dec 4, 25 | CBIOCRESCENT BIOPHARMA, INC. | BUY | 1.36M | $13.41 | $18.2M |
| Oct 7, 25 | ZBIOZenas BioPharma, Inc. | BUY | 316.2K | $19.00 | $6.0M |
| Sep 16, 24 | ZBIOZenas BioPharma, Inc. | BUY | 300.0K | $17.00 | $5.1M |
| Sep 29, 23 | DNTHDianthus Therapeutics, Inc. /DE/ | BUY | 24.7K | $13.63 | $336K |